Correspondence 0001213900-23-049866 from ENZO BIOCHEM INC (ENZ) (CIK 0000316253)
ENZO BIOCHEM INC (ENZ) (CIK 0000316253)
Date: June 20, 2023 · CIK: 0000316253 · Accession: 0001213900-23-049866
AI Filing Summary & Sentiment
File numbers found in text: 333-271911
Show Raw Text
CORRESP
1
filename1.htm
Enzo Biochem, Inc.
81 Executive Blvd., Suite 3
Farmingdale, NY, 11735
June 20, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE:
Enzo Biochem, Inc. (CIK 000316253)
Registration Statement No. 333-271911 on Form S-3 (the “Registration Statement”)
Ladies and Gentlemen:
Enzo Biochem, Inc. (the “Registrant”)
hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities
Act of 1933, as amended (the “Securities Act”), so that it may become effective on June 21, 2023 at 9:30 a.m., Eastern
Time, or as soon thereafter as is practicable.
The undersigned respectfully requests
that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, McDermott Will & Emery LLP,
by calling Richard Bass at (212) 547-5476. The Company hereby authorizes Mr. Bass to orally modify or withdraw this request for acceleration.
Very truly yours,
Enzo Biochem, Inc.
By:
/s/ Hamid Erfanian
Hamid Erfanian
Chief Executive Officer